Forgent is in a volatile recovery phase following a severe drawdown, with the stock up 39.8% over the past six months but still 38.9% below its 52-week high of $66.00. At the current price of $40.35, the shares sit at roughly 36% of the 52-week range (($40.35 - $25.95) / ($66.00 - $25.95)), positioning them in the lower-middle portion of the band — closer to the low than the high, which suggests the market has not fully re-rated the name despite the recent bounce. The 55.66% maximum drawdown from peak to trough underscores how punishing the post-IPO de-rating was, and the fact that price remains well below the highs means overhead supply from earlier buyers is likely to cap rallies. The 1-year price change is not available given the February 2026 listing, so the 6-month gain of 39.8% versus SPY's 17.35% over the same period is the best available proxy for relative performance, and it shows meaningful outperformance on a medium-term basis. Recent momentum is sharply positive but conflicts with the 3-month trend: the stock is up 37.15% in the past month versus SPY's 0.59%, a relative strength of +36.56 percentage points, yet it is down 13.89% over three months with relative strength of -17.23 points. This divergence — strong 1-month, negative 3-month — signals a violent mean-reversion rally off the September lows near $28.64 rather than a clean trend reversal, and the 8.09% single-day jump on October 2 (from $37.33 to $40.35) on volume of 8.76 million shares suggests event-driven buying that may not be sustainable without follow-through. The 3-month weakness also implies the July–August collapse from $64.59 to $29.25 was driven by fundamental or sentiment deterioration that the October bounce has only partially repaired. Key technical levels are well defined: support sits at the 52-week low of $25.95, with a secondary shelf around $28.64–$29.25 where the stock bottomed in late July and mid-September, while resistance is the 52-week high of $66.00, with intermediate resistance likely near the $45–$50 zone where the stock repeatedly stalled in May and June. A breakout above $50 would signal that the market is重新 pricing the AI backlog story and could open a path toward the highs, whereas a breakdown below $28.64 would confirm the recovery as a failed bounce and likely retest $25.95. Beta is not provided in the data, but the 55.66% max drawdown and the 8%+ daily moves imply volatility far in excess of the broader market, which argues for smaller position sizes and wider stops for risk-managed investors.

Forgent's revenue trajectory is nothing short of explosive: Q4 FY2025 (June 2026) revenue reached $461.7 million, up 94.3% year-over-year from $237.6 million in the comparable prior-year quarter, and up 21.9% sequentially from $378.7 million in Q3. The multi-quarter trend shows acceleration rather than deceleration — revenue rose from $283.3 million in Q1 to $296.4 million in Q2, $378.7 million in Q3, and $461.7 million in Q4 — a clear upward staircase that management attributes to AI data center and grid infrastructure demand, supported by a reported ~$3 billion backlog. This growth profile implies the investment case rests almost entirely on execution against that backlog; any slowdown in data center capex or project delays would hit a stock priced for hypergrowth. Profitability is improving but remains thin relative to the growth rate: Q4 net income was $53.3 million on a net margin of 11.5%, up sharply from $0.2 million (0.08% margin) in Q2 and $18.3 million (4.8% margin) in Q3. Gross margin has been relatively stable in the low-30s — 33.5% in Q4 versus 31.1% in Q3 and 29.8% in Q2 — while operating margin expanded to 20.0% in Q4 from 16.3% in Q3 and 6.8% in Q2, helped by operating leverage on higher volume. The key question is whether the 11.5% net margin is a sustainable run-rate or a peak-quarter artifact, especially given $11.4 million of quarterly interest expense that consumes a meaningful share of operating income. The balance sheet carries real leverage: debt-to-equity is 1.25x, the current ratio is 1.54, and total debt to capitalization is 55.5%, with long-term debt to capitalization at 50.5%. Free cash flow is the weak spot — trailing twelve-month FCF is negative $27.0 million, and while Q4 operating cash flow was a healthy $50.4 million, capital expenditures of $31.3 million consumed most of it, leaving just $19.1 million of quarterly FCF. ROE of 14.5% and ROA of 6.0% are respectable but flattered by leverage, and the cash flow to debt ratio of just 0.072 signals that internal cash generation is not yet sufficient to comfortably service and deleverage the balance sheet, meaning Forgent remains dependent on external financing or continued earnings growth to fund its expansion.